Alexia Tellier

1.4k total citations · 1 hit paper
5 papers, 1.1k citations indexed

About

Alexia Tellier is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Alexia Tellier has authored 5 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Alexia Tellier's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). Alexia Tellier is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). Alexia Tellier collaborates with scholars based in France, United States and Italy. Alexia Tellier's co-authors include David Ferry, Radek Lakomý, Teresa Macarulla, Vladimir Moiseyenko, Carmen J. Allegra, Guy A. Van Hazel, Joe McKendrick, Eric Van Cutsem, R Castan and Jana Prausová and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Alexia Tellier

5 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

2012 986 citations Eric Van Cutsem, Josep Tabernero et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexia Tellier France	4	869	394	285	225	170	5	1.1k
Tarek Chidiac United States	11	802 0.9×	384 1.0×	187 0.7×	207 0.9×	137 0.8×	16	1.0k
Federico Nasroulah United States	11	824 0.9×	395 1.0×	190 0.7×	206 0.9×	153 0.9×	29	993
Vicente Alonso-Orduña Spain	7	832 1.0×	402 1.0×	261 0.9×	143 0.6×	140 0.8×	23	1.0k
Joe McKendrick Australia	7	865 1.0×	420 1.1×	292 1.0×	219 1.0×	176 1.0×	9	1.1k
Claus-Christoph Steffens Germany	7	972 1.1×	481 1.2×	310 1.1×	148 0.7×	164 1.0×	18	1.1k
Christopher Hagenstad United States	8	687 0.8×	297 0.8×	198 0.7×	168 0.7×	149 0.9×	14	847
Roger Sidhu United States	13	715 0.8×	388 1.0×	152 0.5×	139 0.6×	248 1.5×	29	904
Mauro D’Amico Italy	10	1.0k 1.2×	414 1.1×	262 0.9×	155 0.7×	284 1.7×	32	1.2k
B. Nelson United States	7	795 0.9×	278 0.7×	199 0.7×	295 1.3×	92 0.5×	12	1.0k
Yevhen Hotko Ukraine	13	1.2k 1.4×	609 1.5×	279 1.0×	206 0.9×	315 1.9×	26	1.4k

Countries citing papers authored by Alexia Tellier

Since Specialization

Citations

This map shows the geographic impact of Alexia Tellier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexia Tellier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexia Tellier more than expected).

Fields of papers citing papers by Alexia Tellier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexia Tellier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexia Tellier. The network helps show where Alexia Tellier may publish in the future.

Co-authorship network of co-authors of Alexia Tellier

This figure shows the co-authorship network connecting the top 25 collaborators of Alexia Tellier. A scholar is included among the top collaborators of Alexia Tellier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexia Tellier. Alexia Tellier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Nicolazzi, Céline, Anne Caron, Alexia Tellier, et al.. (2020). An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities. Molecular Cancer Therapeutics. 19(8). 1660–1669. 23 indexed citations

2.

Caron, Anne, Alexia Tellier, S. Guérif, et al.. (2019). Abstract 235: Preclinical activity of an antibody drug conjugate targeting tumor specificmuc1 structural peptide-glycotope. 235–235. 1 indexed citations

3.

Caron, Anne, Alexia Tellier, S. Guérif, et al.. (2019). Abstract 235: Preclinical activity of an antibody drug conjugate targeting tumor specificmuc1 structural peptide-glycotope. Cancer Research. 79(13_Supplement). 235–235. 4 indexed citations

4.

Gomez‐Roca, Carlos, Valentina Boni, Víctor Moreno, et al.. (2016). A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870).. Journal of Clinical Oncology. 34(15_suppl). 2511–2511. 36 indexed citations

5.

Cutsem, Eric Van, Josep Tabernero, Radek Lakomý, et al.. (2012). Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen. Journal of Clinical Oncology. 30(28). 3499–3506. 986 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact